Watch our Webinar Replay
“Biologics & The Law: Navigate 6 High-Risk Zones”
The regulatory landscape for human-derived biologic products (including exosomes, Wharton’s Jelly, and related biologic materials) is under unprecedented scrutiny from the FDA and state FSMBs. What was once considered a “gray area” has been classified as a “high-risk zone” for legal exposure. This session provides the essential, evidence-based regulatory context required to understand the regulatory landscape for your practice.
Join Our Educational Webinar
“Business Implementation of Biologics in a Cash-Pay Practice”
Wednesday, April 30th, 2025, 7 PM EST
Ready to scale your practice with natural biologics—without relying on insurance?
This business-focused webinar is for providers who want to turn clinical knowledge into actionable strategy. Learn how to build a compliant, sustainable cash-pay model using natural biologic products. Our experts will walk you through the proven “Learn, Launch, Liberate” roadmap and show you how to use education to make science-based, informed decisions in both aesthetics and advanced pain care.
If you wait, you risk being caught relying on outdated compliance knowledge. Stay informed. Register now to secure the clear, evidence-based roadmap your practice requires.
Watch now and take the next step toward building a compliant, future-ready biologic-informed practice.
WATCH NOW
What You’ll Learn:
What You’ll Learn:
Product Definition and Sourcing: Understand why products derived from human tissue are currently treated as unapproved drugs and how to manage the legal risk of product sourcing.
Informed Consent Standards: Dissect the mandatory components for obtaining compliant informed consent as defined by the Federation of State Medical Boards (FSMB).
Communication Audits: Learn the specific communication standards required for marketing and patient education to mitigate risk associated with provider-use biologic manufacturing.
The Unsubstantiated Claim Trap: Identify and eliminate language that regulators classify as high-risk claims of “clarity” or “protection”.
Speakers
Speakers
Brooke Morrisseau
CEO/Founder Ggevityy
